Valsartan

the medication can cause cancer

What is Valsartan

Valsartan is an oral medication prescribed for the treatment of high blood pressure and congestive heart failure. It was approved by the FDA in 1996 under the brand name Diovan®. It is now available in both branded and generic forms.

Valsartan lawsuits claim the drug is contaminated with the toxic chemicals N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), and that both chemicals cause cancer and other major health problems. NDMA is classified as a probable human carcinogen which means it is more likely to cause cancer in humans.

Nearly 3 million Americans take valsartan-containing medications each year. A large-scale recall of generic valsartan blood pressure medications that began in July 2018 led lawyers to investigate claims and file lawsuits on behalf of people who took the tainted medication.

Valsartan Recall
Portrait of a contemplative woman with cancer

Cancers linked to NDMA exposure include:

  • Stomach Cancer
  • Small Intestine Cancer (Adenocarcinoma)
  • Colorectal Cancer
  • Esophageal Cancer
  • Liver Cancer
  • Prostate Cancer (Under the age of 65)
  • Pancreatic Cancer
  • Leukemia
  • Non-Hodgkin’s Lymphoma
  • Multiple Myeloma

Valsartan Recall

“We have carefully assessed the valsartan-containing medications sold in the United States, and we’ve found that the valsartan sold by these specific companies does not meet our safety standards. This is why we’ve asked these companies to take immediate action to protect patients,” said Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research.

The following were named in the recall:

  • Major Pharmaceuticals
  • Solco Healthcare
  • Teva Pharmaceuticals Industries Ltd.
Cropped shot of a pharmacist filling a prescription at a chemist